Spectrum of activity:
|
Gram-positive
&
Gram-negative
|
Details of activity:
|
Active against Staphylococcus aureus, Streptococcus pneumoniae, Enterococcus faecalis, Bacillus anthracis, and Hemophilus influenzae
|
Description:
|
Natural product from Streptomyces cirratus ; shows weak activity against Gram-negatives; erythromycin-resistant staphylococci are cross-resistant to cirramycin
|
Institute where first reported:
|
Bristol-Banyu Research Institute, Ltd.
|
Year first mentioned:
|
1963
|
Development status:
|
Experimental
|